StonvexLoading…
StonvexStonvexStonvexCore line items from ESAB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Annual 2025 2025-12-31 | Q4 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|
Revenue | $745.60M | $2.84B | $2.12B | $1.39B |
Operating Income | $90.48M | $412.17M | $325.56M | $218.94M |
Net Income | $47.64M | $226.77M | $189.09M | $134.25M |
EPS (Diluted) | $0.78 | $3.67 | $3.07 | $2.19 |
Total Assets | $5.62B | $4.77B | $4.87B | $4.43B |
Total Liabilities | $3.39B | $2.55B | $2.71B | $2.32B |
Cash & Equivalents | $1.00B | $185.86M | $218.22M | $258.22M |
Free Cash Flow OCF − CapEx | $33.21M | $213.28M | $135.86M | $65.56M |
Shares Outstanding | 60.88M | 60.72M | 60.52M | 60.52M |